Genes showing upregulated (>2-fold increase) or downregulated (0.5-fold decrease) mRNA expression by 48-hr methylglyoxal treatment. by Kiyoshi Mori (289003)

Adjusted^a mean decrease in days elapsed in the cascade of HCC care post-intervention. by Yapei Zhang (6416108)

“…<p>Adjusted<a href="/article/info:doi/10.1371/journal.pdig.0000080#t004fn001" target="_blank">^a</a> mean decrease in days elapsed in the cascade of HCC care post-intervention.…”

CpG/c stimulated CLL B cells exhibit decreased survival and decreased activation of the Wnt pathway. by Albert Gutierrez Jr. (342562)

PD 98059 decreases the phosphorylation of ERK in HSVEC, but does not restore ATP-induced decrease in endothelial function in RA. by Padmini Komalavilas (402160)

Muscle-specific knockdown of <i>nSMase</i> decreases a subset of ceramide species that are decreased in <i>Gba1b</i> mutants. by Kathryn A. Jewett (3756811)

Effect of DFATs implantation on the inhibition of atrophy in the atrophic vocal fold muscle. by Ikuo Mikoshiba (9312007)

Subjects:

Explanation of condition nodes and decision nodes in the SCM, ordered by decreasing centrality. by Stella D. Juventia (19961247)

Decreased immunofluorescence during multiplex staining. by Sandrine Prost (38667)

“…After each staining round, a slide was mounted and imaged. Analysis of the intensity of Qdots 705Vivid, 605Vivid and 565 fluorescence is shown (Qdot 655Vivid & 525 in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0163856#pone.0163856.s003" target="_blank">S3 Fig</a>) for one representative field (aligned in serial sections). …”

HBx decreases IRS1 expression. by KyeongJin Kim (366271)

Decreased trigger factor association and increased DnaK association with ribosomes furthers protein homeostasis during Mg²⁺ starvation. by Carissa Chan (18310140)

The saturated fatty acid palmitate decreases viability and induces apoptosis in HUVECs. by Dustin M. Lee (8207457)

HA-MAD1 tumors have increased CIN and decreased p53. by Sarah E. Copeland (13951506)

Decreased bleomycin-induced apoptosis in hTERT transfected MLE cells. by Nissim Arish (736264)

“…(B) Flow cytometry analysis demonstrating decreased Annexin V staining in bleomycin-treated hTERT⁺ compared to hTERT^ctrl cells. …”

SCS DKO parasites have decreased mitochondrial ATP content, but are capable of ATP import and ATP hydrolysis. by Gergana Taleva (17131885)

Decrease in preferred walking speed with distance walked for subjects with amputation. by Nidhi Seethapathi (3258591)

Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia by Yiting Zhang (391974)

“…Total Cbl was significantly lower in older control subjects (> 60 yrs of age), primarily reflecting a >10-fold age-dependent decline in the level of MeCbl. …”

RGDfV increases ASM mRNA, ASM activity and ceramide levels and decreases sphingomyelins. by Xiuhai Ren (312555)

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…The overall median rank of VRK1 mRNA overexpression was 947 (out of 19,273 measured genes) (p = 3.64x10^-28). Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10^-5), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10^-5), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10^-22), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10^-71), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10^-28), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10^-12), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10^-10) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10^-17). …”